Desmethyl Levofloxacin
|
|
|
- CAS-Nr.
- 117707-40-1
- Englisch Name:
- Desmethyl Levofloxacin
- Synonyma:
- Levofloxacin Impurity A;N-Desmethyl Levofloxacin;Levofloxacin Related CoMpound A;DN 5455;1,2,3-de>4]oxazino[2;Levofloxacin-1;7-dihydro-2H -[1;Levofloxacin USP RC A;Desmethyl Levofloxacin
- CBNumber:
- CB11176266
- Summenformel:
- C17H18FN3O4
- Molgewicht:
- 347.34
- MOL-Datei:
- 117707-40-1.mol
|
Desmethyl Levofloxacin Eigenschaften
- Schmelzpunkt:
- >184 °C (Dec.)
- Siedepunkt:
- 600.7±55.0 °C(Predicted)
- Dichte
- 1.51±0.1 g/cm3(Predicted)
- storage temp.
- Hygroscopic, -20°C Freezer, Under inert atmosphere
- L?slichkeit
- Aqueous Acid (Slightly, Sonicated), Aqueous Base (Slightly, Sonicated), DMSO (Slightly）
- Aggregatzustand
- Solid
- pka
- 5.19±0.40(Predicted)
- Farbe
- Pale Yellow
- BRN
- 6161512
- CAS Datenbank
- 117707-40-1
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Kennzeichnung gef?hrlicher |
Xn |
|
|
| R-S?tze: |
22 |
|
|
| HS Code |
2934990002 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
|
| Sicherheit |
|
Desmethyl Levofloxacin Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Desmethyl Levofloxacin is a degradation product of levofloxacin. A levofloxacin impurity with antibacterial properties.
Desmethyl Levofloxacin Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Desmethyl Levofloxacin Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 111)Lieferanten
- (3S)-9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid
- Desmethyl Levofloxacin
- DN 5455
- Levofloxacin Related Compound A (25 mg) ((S)-9-fluro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
- N-DesMethyl Levofloxacin (USP RC A)
- Levofloxacin USP Related CoMpound A
- (S)-9-fluro-3-Methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid
- (S)-9-Fluoro-3-methyl-7-oxo-10-(1-piperazinyl)-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid
- Levofloxacin Related Compound A (25 mg) ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid)
- (S)-9-fluoro-3-methyl-7-oxo-10-
(piperazin-1-yl)-2,3-dihydro-7H-
[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- Levofloxacin USP RC A
- 7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylicacid, 9-fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-, (3S)-
- Levofloxacin ImpurityⅢ:LevofloxacinImpurity E{(3S)-9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hydrochloride}
- Ofloxacin Impurity II(Impurity E)
- Levofloxacin Related Compound A(USP)
- Levofloxacin-1
- 1,2,3-de>
- S-(-)-9-fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido-<
- (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
- (S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H -[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride
- Levofloacin Impurity A
- N-desmethyllevofloxacin (levofloxacin related compounds
- Levofloxacin EP Impurity B (N-Desmethyl Levofloxacin)
- S-(-)-9-fluoro-2,3-dihydro-3-methyl-10-(1-piperazinyl)-7-oxo-7H-pyrido-1,2,3-de1,4benzoxazine-6-carboxylicaci
- Desmethyl Levofloxacin USP/EP/BP
- N-Desmethyl Levofloxacin/USP A
- Levofloxacin EP Impurity B/ Levofloxacin Related Compound A (N-Desmethyl Levofloxacin)
- N-Demethyllevofloxacin829
- Levofloxacin Related compound AQ: What is
Levofloxacin Related compound A Q: What is the CAS Number of
Levofloxacin Related compound A Q: What is the storage condition of
Levofloxacin Related compound A Q: What are the applications of
Levofloxacin Related compound A
- (3S)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4- benzoxazine-6-carboxylic Acid
- Levofloxacin Related Compound A ((S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyr (1362114)
- Levofloxacin Related CoMpound A
- N-Desmethyl Levofloxacin
- Levofloxacin Impurity A
- Levofloxacin Impurity 2 (Levofloxacin EP Impurity B)
- Levofloxacin Hemihydrate EP Impurity B
- (S)-9-Fluoro-3-methyl-7-oxo-10-(1-piperazinyl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic Acid
- (S)-9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
- Levofloxacin N-Desmethyl Impurity / Levofloxacin EP Impurity-B / Levofloxacin USP Related Compound-A
- 9-Fluoro-3-methyl-7-oxo-10-(1-piperazinyl)-2,3-dihydro-7H-[1,4]oxazino[2,3,4-Ij]quinoline-6-carboxylic acid
- LEVOFLOXACIN RELATED COMPOUND A (EP IMPURITY B)
- Levofloxacin ImpurityⅢ:LevofloxacinImpurity E{(3S)-9-Fluoro-2,3-dihydro-3-methyl-7-oxo-10-(1-piperazinyl)-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hydrochloride}
- (S)-9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-3
- 4]oxazino[2
- 4-ij]quinoline-6-carboxylic acid hydrochloride
- 7-dihydro-2H -[1
- 117707-40-1
- Chiral Reagents
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals
